1259762

Janssen Pharmaceuticals, Inc. — FEI 1033845

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 24, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Athens, GA (United States)